AGENUS INC (AGEN)
About AGENUS INC
Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $114.2M
- Net income
- -$120.7M
- Total assets
- $226.8M
- Market cap
- $249.0M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $249.0M
- Shares outstanding
- 39.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Feb 4, 2000
Agenus Inc (AGEN) Stock Price
- Reported a net loss of $120.7M in FY2025.
- Trading 36% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review AGENUS INC.
Write a review
News about AGENUS INC
News & sentiment via Polygon.io
Agenus Inc: frequently asked questions
Is Agenus Inc an American company?
Agenus Inc is a US-based company headquartered in Lexington, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Agenus Inc headquartered?
Agenus Inc is headquartered in Lexington, Massachusetts, United States.
Is Agenus Inc publicly traded?
Yes — Agenus Inc is a publicly traded company. Its stock trades under the ticker symbol AGEN on the NASDAQ.
What does Agenus Inc do?
Agenus Inc is an American Pharmaceuticals company in the Health & Beauty sector.
